10 minutes | Jul 9th 2018

157 - FDA clears adipose tissue system for surgical repair; IND application for BAY 1905254; ARISTADA® for schizophrenia; COM701, a first-in-class Immuno-oncology antibody

July 9, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 0:49  Lipogems' Receives FDA Clearance For Microfragmented Adipose Tissue System Utilizing Body's Own Fat To Support Tissue Repair In Orthopaedic And Arthroscopic Surgeries https://www.prnewswire.com/news-releases/fda-clears-the-way-lipogems-receives-fda-clearance-for-microfragmented-adipose-tissue-system-utilizing-bodys-own-fat-to-support-tissue-repair-in-orthopaedic-and-arthroscopic-surgeries-300676836.html  2:28 Compugen Welcomes FDA Clearance of Bayer's IND Application for BAY 1905254 https://www.prnewswire.com/news-releases/compugen-welcomes-fda-clearance-of-bayers-ind-application-for-bay-1905254-300675233.html  3:54 FDA Approves ARISTADA INITIO™ for the initiation of ARISTADA® for schizophrenia https://www.prnewswire.com/news-releases/fda-approves-aristada-initio-for-the-initiation-of-aristada-for-schizophrenia-300675138.html 5:38 Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody https://www.prnewswire.com/news-releases/compugen-announces-fda-clearance-of-ind-application-for-com701-a-first-in-class-immuno-oncology-therapeutic-antibody-884797663.html  7:28 ReCor Medical Announces FDA Approval Of IDE For Pivotal Study Of Paradise® Ultrasound Denervation System For Treatment Of Hypertension https://www.prnewswire.com/news-releases/recor-medical-announces-fda-approval-of-ide-for-pivotal-study-of-paradise-ultrasound-denervation-system-for-treatment-of-hypertension-300675184.html  Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.  Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Play
Like
Play Next
Mark
Played
Share